Libros sobre el tema "Leukemia Chemotherapy"

Ueda, Takanori, ed. Chemotherapy for Leukemia. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-3332-2.

Schmidt, Carolina Witchmichen Penteado y Kaléu Mormino Otoni, eds. Chemotherapy and Pharmacology for Leukemia in Pregnancy. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54058-6.

Heinemann, Volker. Supportive therapy in leukemia patients: Clinical handbook with checklist. Stuttgart ; New York: G. Thieme Verlag ; New York : Thieme Medical Publishers, 1993.

Rebirth: A leukemia survivor's journal of healing during chemotherapy, bone marrow transplant and recovery. [Place of publication not identified]: Xlibris Corp., 2009.

1946-, Cheson Bruce D., Keating Michael J. 1943- y Plunkett William 1943-, eds. Nucleoside analogs in cancer therapy. New York: M. Dekker, 1997.

1951-, Pui Ching-Hon, ed. Treatment of acute leukemias: New directions for clinical research. Totowa, N.J: Humana Press, 2003.

Hancock, Sarah. Fludarabine as first line therapy for chronic lymphocytic leukaemia. Birmingham: University of Birmingham, Department of Public Health and Epidemiology, 2003.

Kaspers, G. J. L., 1963-, Pieters R y International Symposium on Drug Resistance in Leukemia and Lymphoma (3rd : 1998 : Amsterdam, Netherlands), eds. Drug resistance in leukemia and lymphoma III. New York: Kluwer Academic/Plenum Press, 1999.

Heim, Marcel U. The leukemia patient as a partner in therapy: A guidebook for patients, relatives, nurses, and physicians. Stuttgart: GTV Stuttgart, 1994.

Kaspers, G. J. L., 1963-, ed. Drug resistance in leukemia and lymphoma: The clinical value of laboratory studies. Chur, Switzerland: Harwood Academic Publishers, 1993.

W, Hiddemann, ed. Acute leukemias: Pharmacokinetics and management of relapsed and refractory disease. Berlin: Springer-Verlag, 1992.

A handbook of essential drugs and regimens in hematological oncology. Chur: Harwood Academic Publishers, 1991.

Sylvie, St-Hilaire y Bellerive Magalie, eds. L'histoire de Casse-Tête: La pouliche leucémique. Moncton, N.-B: Éditions de la Francophonie, 2006.

Lyman, Gary H. Chemotherapy for Chronic Lymphocytic Leukemia. Oxford University Press, 2012.

Bennett, Lunawati L. Frontiers in Leukemia Pharmacotherapy. Nova Science Publishers, Incorporated, 2019.

Ueda, Takanori. Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2018.

Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2017.

Ueda, Takanori. Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2017.

Bryson, James Scott. Characteristics of reovirus-mediated chemoimmunotherapy of murine L1210 leukemia. 1985.

Farone, Anthony Louis. Interleukin-2 chemoimmunotherapy of murine L1210 leukemia. 1988.

Farone, Anthony Louis. Interleukin-2 chemoimmunotherapy of murine L1210 leukemia. 1988.

Koenigsberg, Adam David. Alpha/Beta and Gamma interferon responses during reovirus-mediated chemoimmunotherapy of L1210 leukemia. 1988.

Heinemann, Volker y Ulrich Jehn. Supportive Therapy in Leukemia Patients (Supportive Measures in Oncology). Thieme Publishing Group, 1992.

Kaspers, G. J. L., 1963-, Pieters R y Veerman A. J. P, eds. Drug resistance in leukemia and lymphoma II. Amsterdam, the Netherlands: Harwood Academic Publishers, 1997.

Gill, Harinder, Yok Lam Kwong y Farhad Ravandi, eds. Acute Promyelocytic Leukemia - Towards a Chemotherapy-Free Approach to Cure in All Patients. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-475-6.

Schmidt, Carolina Witchmichen Penteado y Kaléu Mormino Otoni. Chemotherapy and Pharmacology for Leukemia in Pregnancy: Guidelines and Strategies for Best Practices. Springer International Publishing AG, 2020.

Supportive Measures of Oncology. Thieme-Stratton Corp, 1998.

Farone, Anthony L. Characterization of the immune responses during chemoimmunotherapy of murine L1210 leukemia. 1992.

Roman, Eve, Alexandra Smith y Lorelei Mucci. Leukemias. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0028.

National Institute for Clinical Excellence. Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia. London, 2001.

Haas, David Gerard. Cytotoxic T lymphocyte and natural killer cell responses following chemoimmunotherapy of murine L1210 leukemia. 1986.

Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer, 2011.

Ritter, Jörg, Ursula Creutzig y Günther Schellong. Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer London, Limited, 2012.

Creutzig, U. y J. Ritter. Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer, 1990.

1946-, Creutzig U., Ritter Jörg y Schellong Günther, eds. Acute myelogenous leukemia in childhood: Implications of therapy studies for future risk-adapted treatment strategies. Berlin: Springer-Verlag, 1990.

Linet, Martha S., Lindsay M. Morton, Susan S. Devesa y Graça M. Dores. Leukemias. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0038.

1951-, Pui Ching-Hon, ed. Treatment of acute leukemias: New directions for clinical research. Totowa, N.J: Humana Press, 2003.

Pui, Ching-Hon. Treatment of Acute Leukemias: New Directions for Clinical Research (Current Clinical Oncology). Humana Press, 2003.

Vehling-Kaiser, Ulla y Marcel U. Heim. The Leukemia Patient As Partner in Therapy: A Guidebook for Patients, Relatives, Nurses and Physicians (Supportive Measures in Oncology/Import). Thieme Medical Pub, 1994.

Fridbinstons, Pit Alex. Causes of Thrombocytopenia: Enlarged Spleen, Anemia, Leukemia, Pregnancy, Heavy Alcohol Consumption, Viral Infections, Chemotherapy Medications, Hemolytic Uremic Syndrome, Thrombotic Thrombocytopenic Purpura. Independently Published, 2021.

Cheson. Nucleoside Analogs Cancer Therapy (Basic and Clinical Oncology, 12). Informa Healthcare, 1997.

KAS, GERT-JAN L. Drug Resistance in Leukemia and Lymphoma: The Clinical Value of Laboratory Studies. Taylor & Francis, 1993.

Plunkett, W., M. Keating, W. Hiddemann, T. Büchner y B. Wörmann. Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease. Springer London, Limited, 2012.

Buchner, T. y W. Hiddemann. Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease (Haematologie Und Bluttransfusion). Springer-Verlag, 1992.

Acute Leukaemias (Hamatologie und Bluttransfusion). Springer-Verlag Berlin and Heidelberg GmbH & Co. K, 1992.

1926-, Cacciola E., Deisseroth Albert B. 1941- y Giustolisi R, eds. Hemopoietic growth factors, oncogenes, and cytokines in clinical hematology: Current aspects and future directions. Basel: Karger, 1994.

Negative regulators of hematopoiesis: Studies on their nature, action, and potential role in cancer therapy. New York, N.Y: New York Academy of Sciences, 1991.

Najman, Albert, Athanasius Anagnostou y Nicholas Dainiak. Negative regulators of hematopoiesis : Studies on their nature, action, and potential role in cancer therapy. New York Academy of Sciences, 1991.

Athanasius, Anagostou, Dainiak Nicholas, Najman Albert y International Conference on Negative Regulators of Hematopoiesis, (2nd : 1990 : Providence, R.I.), eds. Negative regulators of hematopoiesis: Studies of their nature, action, and potential role in cancer therapy. New York, N.Y: New York Academy of Sciences, 1991.

Anagnostou, Athanasius y Nicholas Dainiak. Negative Regulators of Hematopoiesis: Studies on Their Nature, Action, and Potential Role in Cancer Therapy (Annals of the New York Academy of Scien). New York Academy of Sciences, 1991.